retatrutide clinical trial dosing ESC 2024: improves lipid and cardiovascular risk profile in Phase II retatrutide clinical trial data done!

Long-Term Maintenance Planning GLP-1 weight loss should include a maintenance plan from the beginning

Because retatrutide does not currently hold regulatory approval in the UK, there are no formal prescribing eligibility criteria in the way that exist for licensed medicines

This unique trifecta of receptor affinity makes Retatrutide a significant focus in biochemical research involving multi-pathway endocrine signaling

There is a theoretical increased risk of medullary thyroid cancers, but its not clear how likely this is to actually happen in people, says Fishman, who along with Vash stresses that the link has only ever been studied in animals